GLP-1 Compound Semaglutide: What It Is, How It's Dosed, and What the Rules Say

GLP-1 compound semaglutide is semaglutide that a licensed compounding pharmacy prepares from bulk active ingredient instead of the drugmaker's finished pen or tablet. It contains the same active molecule found in Ozempic, Wegovy, and Rybelsus, but it is not FDA-approved and it is not interchangeable with those products. Compounded versions spread during the semaglutide shortage between 2022 and 2025, when many patients could not fill a brand-name prescription.

What "GLP-1 Compound Semaglutide" Actually Means

Semaglutide is a GLP-1 receptor agonist. It mimics a gut hormone that slows stomach emptying, increases feelings of fullness, and boosts insulin release after meals. Those effects lower appetite and blood sugar, which is why the drug is prescribed for type 2 diabetes and chronic weight management.

"Compounded" means a pharmacy mixed the medication rather than a manufacturer packaging it. Compounding is legal in the United States when a licensed pharmacy creates a customized product for a patient with a valid prescription. The shorthand glp 1 compound semaglutide is also used loosely online to describe gray-market vials sold as research chemicals, which are a different and far riskier category.

Compounded vs. Brand-Name Semaglutide

Brand-name semaglutide and compounded semaglutide share an active ingredient but almost nothing else about their regulatory path.

Feature	Brand-name (Ozempic, Wegovy, Rybelsus)	Compounded semaglutide
FDA approval	Approved for specific indications	Not FDA-approved
Active ingredient	Semaglutide base	Often semaglutide sodium or acetate
Dose format	Fixed-dose pen or tablet	Vial plus insulin syringe, or pre-filled syringe
Strength	Standard, labeled in milligrams	Varies by pharmacy; often dosed in "units"
Quality oversight	FDA-inspected manufacturing	State board and pharmacy standards
Typical monthly cost	About $900 to $1,400 without insurance	Often $100 to $400

The FDA Ruling Behind the Compound Semaglutide Ban

The FDA removed semaglutide from its drug shortage list on February 21, 2025. That decision triggered a wind-down period for large-scale compounding: 503A pharmacies had until April 22, 2025, and 503B outsourcing facilities had until May 22, 2025, to stop making copies of the drug.

Because of that timeline, most of the compound semaglutide ban is now in effect nationwide. A small number of state-licensed pharmacies still argue that a genuine, patient-specific need allows limited compounding, and the rules keep shifting through litigation and updated FDA guidance.

If you are holding a prescription written before 2025, do not assume it can still be filled. Call the pharmacy first and ask what it is legally able to dispense today.

Compound Semaglutide Doses and Titration

Compounded product is usually drawn into an insulin syringe, so compound semaglutide doses are written in units rather than milligrams. That unit-to-milligram conversion depends entirely on the concentration in the vial, and it is the single biggest source of dosing errors with compounded GLP-1 drugs.

Most clinicians follow a titration schedule similar to the brand-name label:

Weeks	Typical weekly dose	What to watch
1-4	0.25 mg	Starter dose; nausea is common
5-8	0.5 mg	Appetite changes become noticeable
9-12	1.0 mg	Reassess side effects and hydration
13-16	1.7 mg	Weight and A1C response reviewed
17 and later	2.4 mg	Maintenance dose for weight management

Never double a dose to catch up after a missed week. A pharmacist or prescriber should confirm the exact unit mark for your specific vial before the first injection.

Semaglutide B12 Compound: Why Vitamin B12 Is Added

Many formulas are labeled as a semaglutide b12 compound, meaning cyanocobalamin has been blended into the vial. Pharmacies market this as a way to reduce fatigue and nausea, but there is no strong clinical evidence that added B12 changes GLP-1 side effects.

B12 is water-soluble and generally safe at these amounts. The real concern is masking: a B12 injection can normalize lab values while the underlying cause of a deficiency goes unexamined, which matters for people with absorption problems or a vegan diet.

Semaglutide vs. Tirzepatide Compound

Patients often ask what is the difference between semaglutide and tirzepatide compound. The two are not identical drug classes, and their clinical profiles differ.

Feature	Semaglutide	Tirzepatide
Receptor activity	GLP-1 only	GIP and GLP-1
Brand names	Ozempic, Wegovy, Rybelsus	Mounjaro, Zepbound
Top maintenance dose	2.4 mg weekly	15 mg weekly
Average trial weight loss	About 15% of body weight	About 20% of body weight
Common side effects	Nausea, vomiting, diarrhea, constipation	Nausea, vomiting, diarrhea, constipation

Both drugs carry a boxed warning about thyroid C-cell tumors seen in rodents. Both are contraindicated in people with a personal or family history of medullary thyroid cancer or MEN2.

Is Compound Semaglutide Safe?

Doctors cannot call compound semaglutide safe in general, because these products never went through FDA review for safety, effectiveness, or purity. The FDA has received reports of dosing errors, hospitalizations, and products that contained semaglutide sodium instead of semaglutide base.

That does not mean every compounded vial was dangerous. It means the risk depends on the pharmacy, the raw ingredient supplier, and the prescriber's oversight, which are variables a patient usually cannot verify.

• Common side effects: nausea, vomiting, diarrhea, constipation, abdominal pain, fatigue, and headache.
• Serious risks: pancreatitis, gallbladder disease, severe gastroparesis, kidney injury from dehydration, and low blood sugar when combined with insulin or sulfonylureas.
• Red flags: severe persistent abdominal pain, vomiting that prevents fluids, signs of dehydration, or vision changes.

Anyone with a history of pancreatitis, gallbladder disease, kidney disease, or diabetic retinopathy should discuss the risks with a healthcare professional before starting any GLP-1 medication.

What to Ask Before You Fill a Prescription

1. Is this pharmacy licensed in my state, and is it a 503A or 503B facility?
2. Which salt form is in the vial: semaglutide base, sodium, or acetate?
3. What is the exact concentration, and how many units equal 0.25 mg?
4. Who is the bulk ingredient supplier, and can the pharmacy show a certificate of analysis?
5. What is the beyond-use date, and how should the vial be stored?

Bring the vial and syringe to your prescriber for a first-dose demonstration if you have any doubt about the measurement.

Compounded semaglutide filled a real gap during a national shortage, and it helped many patients stay on treatment. With the shortage over and federal enforcement back in place, the safer path for most people is an FDA-approved product, a legitimate clinical trial, or a compounded option arranged directly by a licensed US pharmacy with full transparency about what is in the vial.

COMMON QUESTIONS

Frequently Asked Questions

Is compounded semaglutide the same as Ozempic?

No. Compounded semaglutide contains the same active molecule, but it is not FDA-approved and is not manufactured under the same quality standards as Ozempic. Compounded versions are also typically dosed from a vial with a syringe instead of a fixed-dose pen.

Can I still get compounded semaglutide in the United States?

Most large compounding pharmacies had to stop making semaglutide copies after the FDA ended the shortage in 2025, with deadlines of April 22 and May 22, 2025. A limited number of state-licensed pharmacies argue that patient-specific compounding is still permitted in narrow cases. Check with your state board of pharmacy before paying for anything.

How much does compounded semaglutide cost compared with Ozempic or Wegovy?

Compounded semaglutide typically ran about $100 to $400 per month, while brand-name semaglutide lists for roughly $900 to $1,400 per month without insurance. Some manufacturers now offer discounted cash-pay pricing directly to patients. Cost varies widely by pharmacy, dose, and state.